In search of a target: PD-1 and PD-L1 profiling across glioma types

被引：13
作者：
Berghoff, Anna S. [1 ,2 ,3 ]
Preusser, Matthias [1 ,2 ]
机构：
[1] Med Univ Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria
[2] Med Univ Vienna, Comprehens Canc Ctr CNS Unit CCC CNS, Vienna, Austria
[3] German Canc Res Ctr, German Canc Consortium DKTK, Clin Cooperat Unit Neurooncol, Heidelberg, Germany
来源：
NEURO-ONCOLOGY | 2016年 / 18卷 / 10期
关键词：
TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; PROGNOSTIC IMPACT; GLIOBLASTOMA; EXPRESSION; BLOCKADE; CANCER; CELLS;
D O I：
10.1093/neuonc/now162
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1331 / 1332
页数：2
相关论文
共 13 条
  • [1] Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
    Berghoff, Anna Sophie
    Kiesel, Barbara
    Widhalm, Georg
    Rajky, Orsolya
    Ricken, Gerda
    Woehrer, Adelheid
    Dieckmann, Karin
    Filipits, Martin
    Brandstetter, Anita
    Weller, Michael
    Kurscheid, Sebastian
    Hegi, Monika E.
    Zielinski, Christoph C.
    Marosi, Christine
    Hainfellner, Johannes A.
    Preusser, Matthias
    Wick, Wolfgang
    [J]. NEURO-ONCOLOGY, 2015, 17 (08) : 1064 - 1075
  • [2] Bouffet E., 2016, J Clin Oncol
  • [3] Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma
    Darb-Esfahani, Silvia
    Kunze, Catarina Alisa
    Kulbe, Hagen
    Sehouli, Jalid
    Wienert, Stephan
    Lindner, Judith
    Budczies, Jan
    Bockmayr, Michael
    Dietel, Manfred
    Denkert, Carsten
    Braicu, Ioana
    Joehrens, Korinna
    [J]. ONCOTARGET, 2016, 7 (02) : 1486 - 1499
  • [4] Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies
    Garber, Sarah T.
    Hashimoto, Yuuri
    Weathers, Shiao-Pei
    Xiu, Joanne
    Gatalica, Zoran
    Verhaak, Roel G. W.
    Zhou, Shouhao
    Fuller, Gregory N.
    Khasraw, Mustafa
    de Groot, John
    Reddy, Sandeep K.
    Spetzler, David
    Heimberger, Amy B.
    [J]. NEURO-ONCOLOGY, 2016, 18 (10) : 1357 - 1366
  • [5] Lim Michael, 2016, Am Soc Clin Oncol Educ Book, V35, pe132, DOI 10.14694/EDBK_159084
  • [6] The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
    Louis, David N.
    Perry, Arie
    Reifenberger, Guido
    von Deimling, Andreas
    Figarella-Branger, Dominique
    Cavenee, Webster K.
    Ohgaki, Hiroko
    Wiestler, Otmar D.
    Kleihues, Paul
    Ellison, David W.
    [J]. ACTA NEUROPATHOLOGICA, 2016, 131 (06) : 803 - 820
  • [7] PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells
    Mahoney, Kathleen M.
    Sun, Heather
    Liao, Xiaoyun
    Hua, Ping
    Callea, Marcella
    Greenfield, Edward A.
    Hodi, F. Stephen
    Sharpe, Arlene H.
    Signoretti, Sabina
    Rodig, Scott J.
    Freeman, Gordon J.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2015, 3 (12) : 1308 - 1315
  • [8] PD-L1 expression and prognostic impact in glioblastoma
    Nduom, Edjah K.
    Wei, Jun
    Yaghi, Nasser K.
    Huang, Neal
    Kong, Ling-Yuan
    Gabrusiewicz, Konrad
    Ling, Xiaoyang
    Zhou, Shouhao
    Ivan, Cristina
    Chen, Jie Qing
    Burks, Jared K.
    Fuller, Greg N.
    Calin, George A.
    Conrad, Charles A.
    Creasy, Caitlin
    Ritthipichai, Krit
    Radvanyi, Laszlo
    Heimberger, Amy B.
    [J]. NEURO-ONCOLOGY, 2016, 18 (02) : 195 - 205
  • [9] Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?
    Preusser, Matthias
    Berghoff, Anna S.
    Wick, Wolfgang
    Weller, Michael
    [J]. CLINICAL NEUROPATHOLOGY, 2015, 34 (06) : 313 - 321
  • [10] Prospects of immune checkpoint modulators in the treatment of glioblastoma
    Preusser, Matthias
    Lim, Michael
    Hafler, David A.
    Reardon, David A.
    Sampson, John H.
    [J]. NATURE REVIEWS NEUROLOGY, 2015, 11 (09) : 504 - 514
12